Filter News
Area of Research
- (-) National Security (23)
- (-) Nuclear Science and Technology (9)
- Advanced Manufacturing (3)
- Biology and Environment (25)
- Clean Energy (77)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (6)
- Fusion and Fission (5)
- Isotopes (24)
- Materials (63)
- Materials for Computing (10)
- Neutron Science (100)
- Supercomputing (74)
- Transportation Systems (2)
News Type
News Topics
- (-) Artificial Intelligence (12)
- (-) Big Data (6)
- (-) Exascale Computing (1)
- (-) Isotopes (5)
- (-) Neutron Science (8)
- (-) Transportation (2)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (11)
- Bioenergy (4)
- Biology (5)
- Biomedical (4)
- Biotechnology (1)
- Buildings (1)
- Chemical Sciences (2)
- Climate Change (5)
- Computer Science (21)
- Coronavirus (3)
- Cybersecurity (18)
- Decarbonization (3)
- Energy Storage (2)
- Environment (5)
- Frontier (1)
- Fusion (9)
- Grid (6)
- High-Performance Computing (4)
- Machine Learning (12)
- Materials (2)
- Materials Science (6)
- Molten Salt (4)
- Nanotechnology (1)
- National Security (33)
- Nuclear Energy (37)
- Partnerships (4)
- Physics (3)
- Quantum Science (1)
- Security (11)
- Simulation (1)
- Space Exploration (5)
- Summit (2)
- Sustainable Energy (4)
- Transformational Challenge Reactor (3)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
After more than a year of operation at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL), the COHERENT experiment, using the world’s smallest neutrino detector, has found a big fingerprint of the elusive, electrically neutral particles that interact only weakly with matter.